Effect of Tabashir tablet in treatment of diabetes
Phase 3
- Conditions
- diabetes.Type 2 diabetes mellitus
- Registration Number
- IRCT20230307057648N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 106
Inclusion Criteria
Uncontrolled type 2 diabetes
Age 30-65 years
HbA1c greater than 7 and lower than 8.5
Under treatment with oral diabetes medications (one or more drug groups)
At least one month after increasing the dose of antidiabetic medicine or prescribing a new antidiabetic medicine
Exclusion Criteria
Glomerular filtration rate, lower than 60 ml per minute
Serum albumin, lower than 4 g/dL
SGOT and SGPT, three times higher than normal level
Pregnancy and breastfeeding or intention to become pregnant
Taking insulin along with oral diabetes medications
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood sugar. Timepoint: Blood sugar measurement at the beginning of the study (before the start of the intervention) and three months after taking the Tabashir capsule. Method of measurement: Blood test.
- Secondary Outcome Measures
Name Time Method ipid profile. Timepoint: At the beginning and end of three months of study. Method of measurement: Blood test.